Literature DB >> 19629084

Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

David H Raulet1, Nadia Guerra.   

Abstract

A growing body of research is addressing how pathways that are dysregulated during tumorigenesis are linked to innate immune responses, which can contribute to immune surveillance of cancer. Components of the innate immune system that are localized in tissues are thought to eliminate early neoplastic cells, thereby preventing or delaying the establishment of advanced tumours. This Review addresses our current understanding of the mechanisms that detect cellular stresses that are associated with tumorigenesis and that culminate in the recognition and, in some cases, the elimination of the tumour cells by natural killer cells and other lymphocytes that express natural killer cell receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629084      PMCID: PMC3017432          DOI: 10.1038/nri2604

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  144 in total

1.  A role for skin gammadelta T cells in wound repair.

Authors:  Julie Jameson; Karen Ugarte; Nicole Chen; Pia Yachi; Elaine Fuchs; Richard Boismenu; Wendy L Havran
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

2.  Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

Authors:  Leonidas N Carayannopoulos; Olga V Naidenko; Daved H Fremont; Wayne M Yokoyama
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.

Authors:  Chengming Zhu; Kevin D Mills; David O Ferguson; Charles Lee; John Manis; James Fleming; Yijie Gao; Cynthia C Morton; Frederick W Alt
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

4.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

Authors:  Amanda M Jamieson; Andreas Diefenbach; Christopher W McMahon; Na Xiong; James R Carlyle; David H Raulet
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

5.  Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.

Authors:  Erika Cretney; Kazuyoshi Takeda; Hideo Yagita; Moira Glaccum; Jacques J Peschon; Mark J Smyth
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

6.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Authors:  Veronika Groh; Jennifer Wu; Cassian Yee; Thomas Spies
Journal:  Nature       Date:  2002-10-17       Impact factor: 49.962

7.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.

Authors:  Omid Vafa; Mark Wade; Suzanne Kern; Michelle Beeche; Tej K Pandita; Garret M Hampton; Geoffrey M Wahl
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

8.  Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction.

Authors:  Zhihai Qin; Hye-Jung Kim; Jens Hemme; Thomas Blankenstein
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

9.  A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.

Authors:  Nadine Y Crowe; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

10.  Suppression of lymphoma and epithelial malignancies effected by interferon gamma.

Authors:  Shayna E A Street; Joseph A Trapani; Duncan MacGregor; Mark J Smyth
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  172 in total

Review 1.  Macrophages as mediators of tumor immunosurveillance.

Authors:  Siddhartha Jaiswal; Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Trends Immunol       Date:  2010-05-07       Impact factor: 16.687

Review 2.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 3.  Targeted immunotherapy for acute myeloid leukemia.

Authors:  Sumithira Vasu; Michael A Caligiuri
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-11       Impact factor: 3.020

Review 4.  Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Authors:  Marc Bonneville; Rebecca L O'Brien; Willi K Born
Journal:  Nat Rev Immunol       Date:  2010-06-11       Impact factor: 53.106

5.  In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.

Authors:  J Nakata; K Nakano; A Okumura; Y Mizutani; H Kinoshita; M Iwai; K Hasegawa; S Morimoto; F Fujiki; N Tatsumi; H Nakajima; Y Nakae; S Nishida; A Tsuboi; Y Oji; Y Oka; H Sugiyama; A Kumanogoh; N Hosen
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528

6.  Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune System.

Authors:  Stefano Santaguida; Amelia Richardson; Divya Ramalingam Iyer; Ons M'Saad; Lauren Zasadil; Kristin A Knouse; Yao Liang Wong; Nicholas Rhind; Arshad Desai; Angelika Amon
Journal:  Dev Cell       Date:  2017-06-19       Impact factor: 12.270

7.  Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Authors:  Tao Yin; Guoping Wang; Sisi He; Guobo Shen; Chao Su; Yan Zhang; Xiawei Wei; Tinghong Ye; Ling Li; Shengyong Yang; Dan Li; Fuchun Guo; Zeming Mo; Yang Wan; Ping Ai; Xiaojuan Zhou; Yantong Liu; Yongsheng Wang; Yuquan Wei
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

Review 8.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

9.  The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.

Authors:  Sonja Textor; Felicitas Bossler; Kai-Oliver Henrich; Moritz Gartlgruber; Julia Pollmann; Nathalie Fiegler; Annette Arnold; Frank Westermann; Nina Waldburger; Kai Breuhahn; Sven Golfier; Mathias Witzens-Harig; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-07-28       Impact factor: 8.110

10.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.